Depletion of CCT2 in triple-negative breast cancer (TNBC) cells prevented tumor growth in a murine syngeneic model (Showalter et al., 2020) and impaired the formation of tumor spheroids (Ghozlan et al., 2021). Here, CCT2 is linked to triple-negative breast carcinoma.